As of January 22, 2025, NeoGenomics (NEO) has a market cap of $1.86 billion USD. According to our data, NeoGenomics is ranked No.4240 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.86 B |
-12.01%
|
Dec 31, 2024 | $2.12 B |
1.85%
|
Dec 29, 2023 | $2.08 B |
75.11%
|
Dec 30, 2022 | $1.19 B |
-72.92%
|
Dec 31, 2021 | $4.38 B |
-36.63%
|
Dec 31, 2020 | $6.91 B |
84.07%
|
Dec 31, 2019 | $3.75 B |
131.96%
|
Dec 31, 2018 | $1.62 B |
42.33%
|
Dec 29, 2017 | $1.14 B |
3.38%
|
Dec 30, 2016 | $1.10 B |
8.89%
|
Dec 31, 2015 | $1.01 B |
88.73%
|
Dec 31, 2014 | $0.54 B |
15.19%
|
Dec 31, 2013 | $0.46 B |
45.97%
|
Dec 31, 2012 | $0.32 B |
77.14%
|
Dec 30, 2011 | $0.18 B |
7.69%
|
Dec 31, 2010 | $0.17 B |
-13.33%
|
Dec 31, 2009 | $0.19 B |
145.90%
|
Dec 31, 2008 | $78.30 M |
-43.52%
|
Dec 31, 2007 | $0.14 B |
-28.00%
|
Dec 29, 2006 | $0.19 B |
689.47%
|
Dec 30, 2005 | $24.39 M |
-24.00%
|
Dec 31, 2004 | $32.09 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Quest Diagnostics
DGX
|
$16.91 B |
-0.000 M
|
USA
|
LabCorp
LH
|
$20.28 B |
0.001 M
|
USA
|
OPKO Health
OPK
|
$0.99 B |
-0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
0.000 M
|
USA
|
Personalis
PSNL
|
$0.48 B |
0.000 M
|
USA
|
CareDx
CDNA
|
$1.24 B |
-0.000 M
|
USA
|
Veracyte
VCYT
|
$3.34 B |
-0.000 M
|
USA
|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Market Cap | = | NEO Stock Price | * | NEO Shares Outstanding |
= | $14.50 | * | 0.13 B | |
= | $1.86 B |